Global Proteomics Market report published by Accurize Market Research forecast that the global market is expected to reach $23 billion by 2025; growing at a CAGR of 11.9% from 2017 to 2025. By geography, the Asia Pacific and North America are expected to grow at a CAGR of XX% and XX%, respectively, during the forecast period.

Request Sample:

https://www.accurizemarketresearch.com/report/global-proteomics-market/sample-request

Incessant R&D, technological advancements and increased capital for proteomics projects to drive the growth of the market

Incessant R&D, technological advancements and increased capital for proteomics projects fuel the demand for the global proteomics market. Furthermore, increasing the need for personalized medicine also boosts the growth of the market.

Market Segmentation

The global proteomics market has been bifurcated on the basis of technology, application, industry, and geography. On the basis of technology, the market includes MS-based proteomics technologies and biochip-based proteomics technologies. The proteomics market by application includes cancer, infectious diseases, neurological disorders, cardiovascular diseases, immune diseases, diabetes, and preeclampsia. Further, the industry segment contains mass spectrometry industry, chromatography industry, antibody microarray industry, multiplex protein diagnostics industry, and others. By geography, the market is segmented into North America, Europe, Asia-Pacific, and Rest of the World (RoW).

Customize Report:

https://www.accurizemarketresearch.com/report/global-proteomics-market/ask-for-customization

Top players in the market

The key players are operational in the market includes Thermo Fisher Scientific, Inc., Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Merck KGaA, Danaher Corporation, Luminex Corporation, Perkinelmer, Inc., Waters Corporation, GE Healthcare, and Bruker Corporation among others.